Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells
Open Access
- 1 June 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (26) , 23534-23543
- https://doi.org/10.1074/jbc.m200172200
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC FACTOR IN BLADDER CANCERJournal of Urology, 2001
- Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-α Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein KinaseHypertension, 2000
- Angiostatin Diminishes Activation of the Mitogen-Activated Protein Kinases ERK-1 and ERK-2 in Human Dermal Microvascular Endothelial CellsJournal of Vascular Research, 1999
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998
- Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cellsOncogene, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptorsPublished by Elsevier ,1992
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990